GRACE

cancergrace.org

 

GRACE
K

Lung Cancer Panel Discussion: Should Biomarker Testing Be Performed on Patients With SCC? Are There Ongoing Trials for Rare NSCLC Mutations? What TT Options Exist for Patients With Driver Mutations?

By GRACE FEATURING Kristin Higgins, Aakash Desai, Jessica Lin, Joshua Reuss, Puneeth Iyengar
By GRACE FEATURING Kristin Higgins, Aakash Desai, Jessica Lin, Joshua Reuss, Puneeth Iyengar
0 views
September 11, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Targeted Therapies in Lung Cancer 2023
05:35
GRACE

Lung Cancer Panel Discussion: Resistance on Targeted Therapy - Quest…

Feat. K. Higgins, A. Desai, J. Lin, J. Reuss, P. Iyengar
04:15
GRACE

Lung Cancer Panel Discussion: Why Some Patients Remain on TKIs Witho…

Feat. K. Higgins, A. Desai, J. Lin, J. Reuss, P. Iyengar
05:11
GRACE

Lung Cancer Panel Discussion: What Do We Know About Prevention and C…

Feat. K. Higgins, A. Desai, J. Lin, J. Reuss, P. Iyengar
04:42
GRACE

NSCLC Panel Discussion: Should a Patient With High PD-L1 Wait for Ge…

Feat. K. Higgins, A. Desai, J. Lin, J. Reuss, P. Iyengar
05:26
GRACE

Targeted Therapies in Lung Cancer 2023: Does Radiation Increase Toxi…

Feat. K. Higgins, A. Desai, J. Lin, J. Reuss, P. Iyengar
04:28
GRACE

Targeted Therapies in Lung Cancer 2023: Is Biomarker Testing Common …

Feat. K. Higgins, A. Desai, J. Lin, J. Reuss, P. Iyengar
07:05
GRACE

Lung Cancer Panel Discussion: Should Biomarker Testing Be Performed …

Feat. K. Higgins, A. Desai, J. Lin, J. Reuss, P. Iyengar
20:31
GRACE

Targeted Therapies in Lung Cancer 2023: Novel Treatment Approaches i…

Feat. M. Nagasaka
27:22
GRACE

Targeted Therapies in Lung Cancer 2023: RET and Other Rare Fusions i…

Feat. S. Liu
24:33
GRACE

Targeted Therapies in Lung Cancer 2023: Biomarker Testing for NSCLC …

Feat. A. Desai
20:18
GRACE

Targeted Therapies in Lung Cancer 2023: Non-Metastatic NSCLC and Tar…

Feat. J. Reuss
21:25
GRACE

Targeted Therapies in Lung Cancer 2023: Helping TKIs Maximize Their …

Feat. P. Iyengar
23:50
GRACE

Targeted Therapies in Lung Cancer 2023: EGFR Targeted Therapies in N…

Feat. I. Preeshagul
21:16
GRACE

Targeted Therapies in Lung Cancer 2023: Translating Cancer Discovery…

Feat. J. Sabari
19:14
GRACE

Targeted Therapies in Lung Cancer 2023: Symptom Management and Palli…

Feat. L. Petrillo
02:07
GRACE

Targeted Therapies in Lung Cancer 2023: The Future of Local Therapy

Feat. P. Iyengar
02:41
GRACE

Targeted Therapies in Lung Cancer 2023: Barriers to Biomarker Testin…

Feat. A. Desai
05:37
GRACE

Targeted Therapies in Lung Cancer 2023: The ADAURA Trial for NSCLC -…

Feat. J. Reuss
05:25
GRACE

Targeted Therapies in Lung Cancer 2023: Key Points From the ADAURA T…

Feat. J. Reuss
02:22
GRACE

Targeted Therapies in Lung Cancer 2023: Neoadjuvant Treatment for Pa…

Feat. J. Reuss
04:19
GRACE

Targeted Therapies in Lung Cancer 2023: Biomarker Driven Therapy for…

Feat. A. Desai
03:04
GRACE

Targeted Therapies in Lung Cancer 2023: Current Recommendations and …

Feat. A. Desai
05:02
GRACE

Targeted Therapies in Lung Cancer 2023: Biomarkers in NSCLC

Feat. A. Desai
04:06
GRACE

Targeted Therapies in Lung Cancer 2023: The Importance of Biomarker …

Feat. A. Desai
05:33
GRACE

Targeted Therapies in Lung Cancer 2023: Barriers to Biomarker Testin…

Feat. A. Desai